Advertisement
Advertisement

ACHV

ACHV logo

Achieve Life Sciences, Inc.

4.33
USD
Sponsored
-0.03
-0.57%
Jan 29, 16:00 UTC -5
Closed
exchange

After-Market

4.36

+0.02
+0.46%

ACHV Earnings Reports

Positive Surprise Ratio

ACHV beat 18 of 33 last estimates.

55%

Next Report

Date of Next Report
Mar 09, 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.27
Implied change from Q3 25 (Revenue/ EPS)
--
/
-3.57%
Implied change from Q4 24 (Revenue/ EPS)
--
/
-25.00%

Achieve Life Sciences, Inc. earnings per share and revenue

On Nov 06, 2025, ACHV reported earnings of -0.28 USD per share (EPS) for Q3 25, missing the estimate of -0.26 USD, resulting in a -6.75% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -3.85% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 9 analysts forecast an EPS of -0.27 USD, with revenue projected to reach -- USD, implying an decrease of -3.57% EPS, and increase of 0.00% in Revenue from the last quarter.
FAQ
For Q3 2025, Achieve Life Sciences, Inc. reported EPS of -$0.28, missing estimates by -6.75%, and revenue of $0.00, 0% as expectations.
The stock price moved down -3.85%, changed from $4.93 before the earnings release to $4.74 the day after.
The next earning report is scheduled for Mar 09, 2026.
Based on 9 analysts, Achieve Life Sciences, Inc. is expected to report EPS of -$0.27 and revenue of -- for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement